168 related articles for article (PubMed ID: 34356990)
1. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer.
Jaafar RF; Ibrahim Z; Ataya K; Hassanieh J; Ard N; Faraj W
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356990
[No Abstract] [Full Text] [Related]
2. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
3. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation.
Jiao J; Ruan L; Cheng CS; Wang F; Yang P; Chen Z
Mol Med; 2023 Apr; 29(1):47. PubMed ID: 37016317
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells.
Wu S; Kanda T; Nakamoto S; Imazeki F; Yokosuka O
Anticancer Res; 2012 Sep; 32(9):3775-83. PubMed ID: 22993319
[TBL] [Abstract][Full Text] [Related]
5. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours.
Zhang H; Ma Y; Zhang Q; Liu R; Luo H; Wang X
BMC Med Genomics; 2022 Apr; 15(1):97. PubMed ID: 35473583
[TBL] [Abstract][Full Text] [Related]
6. High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer.
Shen Y; Lin H; Chen K; Ge W; Xia D; Wu Y; Lu W
J Ovarian Res; 2022 Apr; 15(1):48. PubMed ID: 35477477
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA.
Li X; Li Z; Zhu H; Yu X
Biomed Res Int; 2020; 2020():8537381. PubMed ID: 33204717
[TBL] [Abstract][Full Text] [Related]
8. RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Li D; Tang L; Liu B; Xu S; Jin M; Bo W
Aging (Albany NY); 2021 Mar; 13(7):10450-10467. PubMed ID: 33790054
[No Abstract] [Full Text] [Related]
9. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs).
Yuan X; Chen Y; Tang M; Wei Y; Shi M; Yang Y; Zhou Y; Yang T; Liu J; Liu K; Deng D; Zhang C; Chen L
J Med Chem; 2022 Jul; 65(13):9312-9327. PubMed ID: 35709396
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
12. RIPK2 inhibitors for disease therapy: Current status and perspectives.
Tian E; Zhou C; Quan S; Su C; Zhang G; Yu Q; Li J; Zhang J
Eur J Med Chem; 2023 Nov; 259():115683. PubMed ID: 37531744
[TBL] [Abstract][Full Text] [Related]
13. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells.
Madrigal AG; Barth K; Papadopoulos G; Genco CA
PLoS Pathog; 2012; 8(6):e1002723. PubMed ID: 22685397
[TBL] [Abstract][Full Text] [Related]
15. Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.
Guirado M; Gil H; Saenz-Lopez P; Reinboth J; Garrido F; Cozar JM; Ruiz-Cabello F; Carretero R
Hum Immunol; 2012 Jun; 73(6):668-72. PubMed ID: 22504414
[TBL] [Abstract][Full Text] [Related]
16. Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.
Park JY; Lee TS; Noh EJ; Jang AR; Ahn JH; Kim DY; Jung DH; Song EJ; Lee YJ; Lee YJ; Lee SK; Park JH
Am J Reprod Immunol; 2021 Jul; 86(1):e13403. PubMed ID: 33580557
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2.
Wagner RN; Reed JC; Chanda SK
Retrovirology; 2015 Aug; 12():74. PubMed ID: 26297639
[TBL] [Abstract][Full Text] [Related]
18. The RIPK2 gene: a positional candidate for tick burden supported by genetic associations in cattle and immunological response of knockout mouse.
Porto Neto LR; Jonsson NN; Ingham A; Bunch RJ; Harrison BE; Barendse W;
Immunogenetics; 2012 May; 64(5):379-88. PubMed ID: 22314416
[TBL] [Abstract][Full Text] [Related]
19. RIPK2 NODs to XIAP and IBD.
Topal Y; Gyrd-Hansen M
Semin Cell Dev Biol; 2021 Jan; 109():144-150. PubMed ID: 32631784
[TBL] [Abstract][Full Text] [Related]
20. RIPK2 polymorphisms and susceptibility to tuberculosis in a Western Chinese Han population.
Song J; Liu T; Jiao L; Zhao Z; Hu X; Wu Q; Bai H; Lv M; Meng Z; Wu T; Chen H; Chen X; Song X; Ying B
Infect Genet Evol; 2019 Nov; 75():103950. PubMed ID: 31279003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]